The Wellcome Trust Sanger Institute responds to the Life Sciences Industrial Strategy

The Life Sciences Industrial Strategy recognises the key role genomics and genetics will play in future healthcare provision

The Wellcome Trust Sanger Institute responds to the Life Sciences Industrial Strategy

The report, written by Life Science’s Champion Professor Sir John Bell, provides recommendations to government on the long-term success of the life sciences sector.

Below Dr Julia Wilson gives the Wellcome Trust Sanger Institute's response.

Julia Wilson, Associate Director, Sanger InstituteGenome Research Limited
Julia Wilson, Associate Director, Sanger Institute

“The Wellcome Trust Sanger Institute welcomes the release of the Life Sciences: Industrial Strategy, which recognises that genomics, data and research are the key to realising transformative health care in the UK. The Sanger Institute has been at the cutting edge of world-leading genomic research for nearly 25 years, and continues to create the foundation for new genomic technologies for healthcare.

This Life Science Strategy offers a framework for UK research to support and deliver a world-leading healthcare system. We welcome the recommendations for creating a Health Advanced Research Programme, and to support that we encourage the government to implement the recommendations made by this Institute and Dame Sally Davies in her recent report, Generation Genome.

The Sanger Institute remains committed to powering the genomic revolution.”

Dr Julia Wilson, associate director of the Wellcome Trust Sanger Institute

Notes to Editors

Publications:

Life sciences: industrial strategy

The report, written by Life Science’s Champion Professor Sir John Bell, provides recommendations to government on the long-term success of the life sciences sector.

Chief Medical Officer annual report 2016: Generation Genome

Professor Dame Sally Davies’s eighth independent report to government as CMO looks at how genomics can improve health and prevent ill-health

Sanger Institute response to Genome Generation Report

The UK Chief Medical Officer's report has highlighted the key role genomics and genetics will play in future healthcare provision. Associate director Dr Julia Wilson and honorary faculty member Professor Sharon Peacock comment

Selected Websites
Contact the Press Office

Dr Samantha Wynne, Media Officer

Tel +44 (0)1223 492 368

Emily Mobley, Media Officer

Tel +44 (0)1223 496 851

Wellcome Trust Sanger Institute,
Hinxton,
Cambridgeshire,
CB10 1SA,
UK

Mobile +44 (0) 7900 607793

Recent News

Genome editing reveals role of gene important for human embryo development

CRISPR-Cas9 genome editing shows that the protein OCT4 is essential in very early days of human embryo development

Huge genetic diversity among Papuan New Guinean peoples revealed

Genetic diversity found to mirror linguistic and cultural diversity among Papuan New Guinean people

Immunotherapy treatment option for selected breast cancer patients, genetic study suggests

Opens up the possibility of another therapy option for approximately 1,000 breast cancer patients in the UK